Overview

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

Status:
Completed
Trial end date:
2021-05-05
Target enrollment:
Participant gender:
Summary
The study examines the Safety and efficacy study of exenatide once weekly in children and adolescents with type 2 diabetes
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Exenatide